← Back to Search

Probiotic

Goodbelly for Peripheral Vascular Disease

N/A
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 24 hours after consumption and approximately 7 days after consumption
Awards & highlights

Summary

This trial is testing whether a drug that improves FMD can also reduce the risk of cardiovascular disease.

Eligible Conditions
  • Peripheral Vascular Disease
  • High Cholesterol
  • Cerebral Artery Disease
  • High Blood Pressure
  • Coronary Artery Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 24 hours after consumption and approximately 7 days after consumption
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 24 hours after consumption and approximately 7 days after consumption for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in baseline flow mediated dilation (FMD) after probiotic consumption
Secondary outcome measures
Interleukin-12
Interleukin-6
Interleukin-8

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: GoodBelly ProbioticExperimental Treatment1 Intervention
Subjects randomized to this arm consume one serving of the Goodbelly lactobacillus plantarum 299v probiotic
Group II: PlaceboPlacebo Group1 Intervention
Subjects randomized to this arm consume one serving of the Goodbelly that does not contain lactobacillus plantarum 299v
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Goodbelly
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
614 Previous Clinical Trials
1,162,853 Total Patients Enrolled
~5 spots leftby Jul 2025